注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
Orgenesis Inc是一家致力于开发细胞和基因潜在疗法(CGT)的生物技术公司。该公司专注于自体疗法,采用封闭和自动化的处理系统方法,经过验证,可在患者护理点 (POCare)附近进行合规生产以进行治疗。该公司开发了一个由三个支持组件组成的护理点平台(POCare Platform),其中包括旨在加工和生产的POCare先进疗法管道、自动化封闭式POCare技术系统以及POCare研究机构的全球网络和医院(POCare 网络)。其临床使用的产品包括KYSLECEL、用于细胞辅助脂肪转移的Tissue Genesis Icellator、用于治疗骨关节炎的Cartil-S自体产品和用于治疗软骨缺损的Chondroseal自体产品。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Jay S. Skyler | 74 | 2013 | Member of Advisory Board |
Yaron Adler | 50 | 2012 | Independent Director |
Vered Caplan | 52 | 2012 | Chairperson of the Board, CEO & President |
G. Alexander Fleming | - | 2012 | Member of Advisory Board |
David Sidransky | 61 | 2013 | Independent Director |
Lorenzo Piemonti | - | 2018 | Member of Advisory Board |
Bala S. Manian | 76 | 2019 | Member of Advisory Board |
Mario Philips | 51 | 2020 | Independent Director |
Micha Drukker | - | - | Member of Advisory Board |
Joseph Press | 67 | - | Member of Advisory Board |
Ashish Nanda | 56 | 2017 | Independent Director |
Stephen Minger | - | 2020 | Member of Advisory Board |
Guy Yachin | 53 | 2012 | Independent Director |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核